Direct Meds and the 2026 Insurance Coverage Loss Landscape Why 24 Million Americans Are Searching for GLP-1 Like Direct Meds Right Now Between 2025 and 2026 an estimated 24 million Americans lost insurance coverage for GLP-1 medications as major pharmacy benefit managers dropped GLP-1s from their formularies and employers restructured health benefits to manage pharmacy cost growth
Some drugs have been proposed to accelerate -cell loss (e.g., glibenclamide and glyburide) [23], while other drugs such as peroxisome proliferator-activated receptor-gamma (PPAR) agonists, GLP-1 receptor agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors, glycogen synthase kinase 3 (GSK3) inhibitors, or G protein-coupled receptor 40 (GPR40) agonists have been suggested to protect -cell function [16]
Dose escalation follows a gradual 4-week titration schedulemoving from 2.5 mg to 5 mg, then 7.5 mg, and potentially 10 or 15 mg depending on clinical response and side-effect profile
PLoS One 8:e83199 Borisova MM, Kozuleva MA, Rudenko NN, Naydov IA, Klenina IB, Ivanov BN (2012) Photosynthetic electron flow to oxygen and diffusion of hydrogen peroxide through the chloroplast envelope via aquaporins
